查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405834

MicroRNA 市场规模、份额和趋势分析报告：按产品/服务、最终用途、地区和细分市场进行预测，2024-2030 年

MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Instruments, Consumables), By Application (Cancer, Infectious Diseases) By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

MicroRNA 市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球microRNA市场规模将达到36.4亿美元，2024年至2030年复合年增长率为12.87%。

市场开拓是由对开发新型诊断测试和治疗方法的研发计划的大量投资，以及 microRNA 在临床试验中的成功整合所推动的。生物製药板块在当前生物技术产业中发挥重要作用。生技产业的研发支出大幅增加。多家生物製药公司正在投资开发基于 RNA 的疗法（miRNA 和 siRNA）。主要公司包括 Regulus Therapeutics、Rosetta Genomics、Alnylam Pharmaceuticals、miRagen Therapeutics 和 Mirna Therapeutics。

大量投资，加上政府对 miRNA 研究和开发的资助不断增加，以开发新的诊断测试和治疗方法，预计将推动市场成长。一些新参与企业已经进入市场，采用创新方法开发标靶治疗疗法和识别药物研发标靶。例如，在 2022 年 4 月发表在 Elsevier 上的一篇论文中，研究团队概述了目前的大型队列研究，证明了循环 miRNA 对于疾病早期诊断的临床价值。

越来越多的研究调查各种 microRNA 的肿瘤抑製作用，特别是在乳腺癌等细胞株中，正在推动对 microRNA 研究工具的需求不断增加。此外，基于miRNA的疗法在治疗各种疾病方面显示出巨大的潜力，并且不断发展。将基于 miRNA 的治疗药物精确地递送至目标细胞仍然是临床应用的主要挑战。然而，最近引入的高效递送系统，例如基于奈米粒子的递送系统，预计将有助于克服这项挑战。

MicroRNA 市场报告亮点

  • 按产品/服务划分，服务领域将主导市场，其可提供分离/精製、miRNA cDNA合成、分析、定位、定量和功能分析等广泛的服务，收益占有率最高，为58.8%。2023. 做到了。
  • 从应用来看，由于对使用 miRNA 特征的癌症研究进行了大量投资，肿瘤学领域在 2023 年占据了最高的收益占有率。
  • 按最终用途划分，生物技术和製药公司细分市场将在 2023 年以最高收益占有率占据市场主导地位。这是因为我们有能力与研究机构建立合作和伙伴关係，使我们能够获得前沿研究并在大型计划上进行合作。
  • 由于该地区存在主要市场参与者，北美将在 2023 年主导全球产业。

目录

第一章调查方法与范围

第 2 章 MicroRNA (miRNA) 市场：执行摘要

  • 市场概述
  • 产品和服务简介
  • 应用程式和最终使用简介
  • 竞争形势概览

第 3 章 MicroRNA (miRNA) 市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 2019冠状病毒病爆发
    • miRNA 应用的最新创新
    • 对 miRNA 研究和开发倡议进行大量投资，以开发新的诊断测试和治疗方法
    • miRNA在临床试验中取得成功
    • 支持核酸研究的技术进步
    • 序列成本指数下降
  • 市场抑制因素分析
    • 与 microRNA套件和其他产品相关的高成本
    • RNA 处理和内部开发 microRNA 检测方法的挑战
    • 研究重现性和产品特异性较差
    • 新兴市场的生命科学研究基础设施有限
  • 营商环境分析
    • 波特五力分析
    • PESTLE分析
  • COVID-19 分析

第四章 产品和服务的估算和趋势分析

  • MicroRNA（miRNA）市场：产品波动分析
  • 装置
    • 2018-2030 年设备市场估计与预测
    • 科技
    • 工作流程
  • 消耗品
    • 2018-2030 年消耗品市场估计与预测
    • 检体
    • 工作流程
  • 服务
    • 2018-2030 年服务类型市场估计与预测
    • 分离精製
    • miRNA cDNA 合成
    • 分析、本地化和认证
    • 泛函分析
    • 其他的
  • 检体
    • 2018-2030 年检体市场估计与预测
    • 全血
    • 血清
    • 电浆
    • FFPE
    • 新鲜冷冻组织
    • 其他的

第五章 应用预估/趋势分析

  • MicroRNA (miRNA) 市场：应用变化分析
  • 癌症
    • 2018-2030年癌症市场收益估算与预测
  • 感染疾病
    • 2018-2030年感染疾病市场收益估计与预测
  • 免疫疾病
    • 2018-2030年免疫疾病市场收益估算与预测
  • 循环系统疾病
    • 2018-2030年循环系统疾病市场收益估算与预测
  • 神经系统疾病
    • 2018-2030年神经系统疾病市场收益估计与预测
  • 其他的
    • 2018-2030 年其他市场收益估计与预测

第 6 章 最终用途估算/趋势分析

  • MicroRNA (miRNA) 市场：最终用途变异分析
  • 生技/製药公司
    • 2018-2030 年生物技术和製药公司市场收益估计和预测
  • 学术和政府研究组织
    • 2018-2030 年学术和政府研究机构市场收益估计和预测
  • 其他最终用户
    • 2018-2030 年其他最终用户市场收益估计与预测

第七章 区域业务分析

  • 区域市场简介
  • 北美洲
    • 北美微小RNA
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲微小RNA
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区微小RNA
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲微小RNA
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 来自中东和非洲的 MicroRNA
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 公司分类
  • 策略规划
    • 获得
    • 产品/服务发布
    • 伙伴关係/协作
    • 其他的
  • 2023 年市场分析
  • 公司简介
    • Thermo Fisher Scientififc, Inc
    • QIAGEN
    • Horizon Discovery Group Co.
    • NanoString Technologies, Inc
    • Merck KGaA
    • Takara Bio, Inc
    • LGC Limited
    • BioGenex
    • GeneCopoeia, Inc
    • New England Biolabs
Product Code: GVR-2-68038-368-3

MicroRNA Market Growth & Trends:

The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

MicroRNA Market Report Highlights:

  • Based on products & services, the services segment dominated the market with the highest revenue share of 58.8% in 2023, due to its ability to provide wide services such as isolation & purification, miRNA cDNA synthesis, profiling, localization, & quantification, functional analysis, and others
  • Based on application, the cancer segment dominated the segment with the highest revenue share in 2023, due to high investments in cancer research adopting miRNA signatures
  • Based on end-use, the biotechnology & pharmaceutical companies segment dominate the market with the highest revenue share in 2023, due to their ability to establish collaborations and partnerships with research institutions that allow them to access cutting-edge research and collaborate on large-scale projects
  • North America dominated the global industry in 2023 owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. MicroRNA (miRNA) Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products and Services Snapshots
  • 2.3. Application and End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. MicroRNA (miRNA) Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Outbreak of COVID - 19
    • 3.4.2. Recent innovation in application of miRNAs
      • 3.4.2.1. Increased adoption for use as a biomarker
      • 3.4.2.2. Therapeutic applications
    • 3.4.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
    • 3.4.4. The success of miRNA in clinical trials
    • 3.4.5. Technological advancements to support nucleic acid studies
    • 3.4.6. Exponentially declining cost of sequencing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with microRNA kits and other products
    • 3.5.2. Challenges in handling RNA & in-house development of assays for microRNA detection
    • 3.5.3. Poor reproducibility of research and specificity of products
    • 3.5.4. Limited life science research infrastructure in emerging markets
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
  • 3.7. COVID-19 Analysis

Chapter 4. Products & Services Estimates & Trend Analysis

  • 4.1. MicroRNA (miRNA) Market: Products Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Technology
      • 4.2.2.1. Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.2. Real-Time PCR
      • 4.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.3. Microarray
      • 4.2.2.3.1. Microarray Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.4. NGS
      • 4.2.2.4.1. NGS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.5. Others
      • 4.2.2.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Workflow
      • 4.2.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.2. Isolation & Purification
      • 4.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.3. miRNA cDNA Synthesis
      • 4.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.4. Profiling, Localization, & Qualification
      • 4.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.5. Functional Analysis & Others
      • 4.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.6. Others
      • 4.2.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Specimen
      • 4.3.2.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Whole Blood
      • 4.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Serum
      • 4.3.2.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Plasma
      • 4.3.2.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. FFPE
      • 4.3.2.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.6. Fresh Frozen Tissue
      • 4.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.7. Others
      • 4.3.2.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Workflow
      • 4.3.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Isolation & Purification
      • 4.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. miRNA cDNA Synthesis
      • 4.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4. Profiling, Localization, & Qualification
      • 4.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Functional Analysis & Others
      • 4.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.6. Others
      • 4.3.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Service Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Isolation & Purification
      • 4.4.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. miRNA cDNA Synthesis
      • 4.4.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Profiling, Localization, & Qualification
      • 4.4.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Functional Analysis
      • 4.4.5.1. Functional Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Specimen
    • 4.5.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Whole Blood
      • 4.5.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum
      • 4.5.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Plasma
      • 4.5.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. FFPE
      • 4.5.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Fresh Frozen Tissue
      • 4.5.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Estimates & Trend Analysis

  • 5.1. MicroRNA (miRNA) Market: Application Movement Analysis
  • 5.2. Cancer
    • 5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Infectious Diseases
    • 5.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Immunological Disorder
    • 5.4.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Disease
    • 5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological Disease
    • 5.6.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-use Estimates & Trend Analysis

  • 6.1. MicroRNA (miRNA) Market: End-use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Government Research Institutes
    • 6.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Other End-users
    • 6.4.1. Other End-users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. UK MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. Germany MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. Spain MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. France MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Italy MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Microrna (Mirna) Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Thailand MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Australia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. Acquisition
    • 8.2.2. Product/Service Launch
    • 8.2.3. Partnerships/Collaborations
    • 8.2.4. Others
  • 8.3. Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientififc, Inc
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. QIAGEN
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Horizon Discovery Group Co.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. NanoString Technologies, Inc
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Takara Bio, Inc
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. LGC Limited
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. BioGenex
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. GeneCopoeia, Inc
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 4 Global MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 6 Global MicroRNA Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 9 North America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 12 U.S. MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 14 Canada MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 15 Canada MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 17 Europe MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 19 Europe MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Europe MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 21 Germany MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 22 Germany MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Germany MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 24 UK MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 25 UK MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 UK MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 27 France MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 28 France MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 France MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 30 Italy MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 31 Italy MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Italy MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 33 Spain MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 34 Spain MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Spain MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 36 Denmark MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 37 Denmark MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 39 Norway MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 40 Norway MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Norway MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 42 Sweden MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 43 Sweden MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 50 China MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 51 China MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 China MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 53 Japan MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 54 Japan MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Japan MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 56 India MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 57 India MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 India MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 59 South Korea MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 60 South Korea MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 62 Australia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 63 Australia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Australia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 65 Thailand MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 66 Thailand MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 68 Latin America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 69 Latin America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 71 Brazil MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 72 Brazil MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 74 Mexico MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 75 Mexico MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 77 Argentina MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 78 Argentina MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 84 South Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 85 South Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 90 UAE MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 91 UAE MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 93 Kuwait MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 94 Kuwait MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait MicroRNA Market, End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mineral Supplements, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 15 Global MicroRNA Market: Products & Services Movement Analysis
  • Fig. 16 Global MicroRNA Market, for Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global MicroRNA Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global MicroRNA Market, for Technology, 2018 - 2030 (USD Million)
  • Fig. 19 Global MicroRNA Market, for Real-Time PCR, 2018 - 2030 (USD Million)
  • Fig. 20 Global MicroRNA Market, for Microarray, 2018 - 2030 (USD Million)
  • Fig. 21 Global MicroRNA Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 22 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 24 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 27 Global MicroRNA Market, for Functional Analysis & Others, 2018 - 2030 (USD Million)
  • Fig. 28 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global MicroRNA Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 30 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 31 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 32 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 33 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 34 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 36 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 38 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 41 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 42 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Global MicroRNA Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 44 Global MicroRNA Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 45 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 48 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 49 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 50 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 51 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 52 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 53 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 54 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 56 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 57 Global MicroRNA Market: Application Movement Analysis
  • Fig. 58 Global MicroRNA Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 59 Global MicroRNA Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 60 Global MicroRNA Market, for Immunological Disorder, 2018 - 2030 (USD Million)
  • Fig. 61 Global MicroRNA Market, for cardiovascular disease, 2018 - 2030 (USD Million)
  • Fig. 62 Global MicroRNA Market, for Neurological Disease, 2018 - 2030 (USD Million)
  • Fig. 63 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 64 Global MicroRNA Market: End-Use Movement Analysis
  • Fig. 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 67 Global MicroRNA Market, for Other end-users, 2018 - 2030 (USD Million)
  • Fig. 68 Regional Marketplace: Key Takeaways
  • Fig. 69 Regional Outlook, 2022 & 2030
  • Fig. 70 Global MicroRNA Market: Region Movement Analysis
  • Fig. 71 North America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 72 U.S. MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 73 Canada MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 74 Europe MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 75 Germany MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 76 UK MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 77 France MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 78 Italy MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 79 Spain MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 80 Denmark MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 81 Norway MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 84 Japan MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 85 China MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 86 India MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 87 Thailand MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 88 Australia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 91 Brazil MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 92 Mexico MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 93 Argentina MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East and Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 95 South Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 97 UAE MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait MicroRNA Market, 2018 - 2030 (USD Million)